Download our decentralized trials handbook
Download our handbook on decentralized trials
Discover the applications and benefits of remote health monitoring to effectively decentralize clinical trials.Request a copy
embrace for research
Decentralize your trials with digital endpoints and a powerful end-to-end platform
A complete platform for decentralized, virtual, and hybrid clinical trials
Embrace for Research is a fully integrated platform for conducting real-world trials across multiple sites. Empatica’s powerful Embrace2 and EmbracePlus wearables can continuously and accurately record and send physiological information to the cloud, enabling virtually unlimited data and scalability. And through the Research Portal, researchers can cost-effectively conduct multi-site studies and analyze data remotely and securely, accelerating their findings and reducing costs.
Build a research team and check the progress of multiple sites at a glance
Each study or site created is isolated, you can fine-tune access levels for each team member
By deploying a one-time-use QR code scan, we simplify subject enrollment while ensuring that there are no ID errors
Optimal research platform
Review deployed device status and monitor subject compliance in real time
SLEEP APNEA STUDY
Sleep Revolution H2020
The Sleep Revolution, an interdisciplinary international research and development project, aims to develop a smart, personalized diagnostic and therapeutic solution for sleep-disordered breathing (sleep apnea). Using the EmbracePlus smartwatch, the study entails developing Machine Learning models to determine the severity and treatment needs of people with sleep apnea, for accurate diagnosis and improved treatment.
TIMESPAN, a consortium of 17 institutions from 14 countries has launched the ART-CARMA project, to study the management of chronic cardiometabolic disease and treatment discontinuity in adult ADHD patients. Using EmbracePlus, the project aims to understand the risks of cardiometabolic illnesses such as cardiovascular disease and obesity for adults with ADHD, and how their future health can best be improved through medication.
DIGITAL ENDPOINT VALIDATION STUDY
VeraSci’s Innovation Lab has been conducting an NIH-funded study examining the relationship between real-time measurements of gait and actigraphy, collected by the Embrace2, and established cognitive and functional endpoints that are sensitive to decline early in the Alzheimer’s disease continuum. Their preliminary data suggest a positive correlation between in-clinic measurements and the endpoints developed using Embrace2 data for monitoring the patient's cognitive health.Download the case study
DRUG EFFICIENCY TRIAL
Sunovion Pharmaceuticals utilized Empatica’s decentralized trials platform during their international multi-site phase-4 anti-epileptic drug trial. Empatica’s FDA-cleared seizure detection algorithm and the e-diary app allowed Sunovion to continuously monitor patients, gaining an objective insight into seizure counts while remotely monitoring compliance throughout the study.
FLU PREVENTION STUDY
Biomedical Advanced Research and Development Authority
The US government’s Biomedical Advanced Research and Development Authority (BARDA) has partnered with Empatica to develop a digital endpoint for detecting the earliest signs of the flu. Through the use of the Embrace2 wearable and Empatica data analysis expertise, they engaged in a prospective study monitoring healthy individuals throughout the flu season with the aim to develop an early detection system. Following the outbreak of the Covid-19 pandemic, BARDA and Empatica renewed their partnership to utilize EmbracePlus and the Care suite for Covid-19 early detection.
MENTAL HEALTH STUDY
Harvard University Clinical Psychologist Dr. Matthew K. Nock is using Embrace for Research to detect digital phenotypes related to suicidal thoughts in a multi-site study involving hundreds of individuals wearing Embrace2. This is the largest-yet study about suicidal behavior also measuring skin conductance levels as an objective way to assess changes in physiological distress in the participants.
4YouandMe, a non-profit company founded by Dr. Stephen H. Friend has partnered with clinicians at Oxford University and Mount Sinai School of Medicine to conduct a multi-site prospective cohort study, utilizing Empatica wearables to monitor signs of stress and symptoms of Crohn's disease. The aim of this project is to provide biofeedback to patients with Crohn’s, in order to potentially prevent negative clinical changes in their condition.
ZERO GRAVITY STUDY
MIT Media Lab
MIT Media Lab’s doctoral student, Kristina T. Johnson has embarked on a journey to measure autonomic changes in parabolic flyers. Parabolic flight planes are notorious for inducing high levels of nausea. By using Empatica’s technology and other biosignal measures, Kristy and her team were able to gain an objective insight into novice and veteran flyers’ physiological well-being during flights.
Pear Therapeutics, the leader in prescription digital therapeutics, is using Empatica’s technology to explore using wearable sensors in the evaluation of withdrawal symptoms in patients with substance use disorder (SUD), opioid use disorder (OUD), and alcohol use disorder (AUD). Using the EmbracePlus smartwatch, Pear Therapeutic aims to integrate real-time personalization of digital therapeutic content and pharmaceutical dosing to patients across disease stages.
How does Embrace for Research work?
Continuous and accurate participant data
A medical-grade wearable to continuously measure physiological parameters, giving insights into sleep, activity, autonomic arousal, and seizures for many different typologies of clinical/research studies.
Collect objective biometric data
EDA, PPG, Accelerometer and Gyroscope
Non-stop data collection
Thanks to sophisticated sensors, on-board memory and continuous data streaming
Continuous monitoring of the Sympathetic Nervous System
The only smartwatches to offer continuous EDA data streaming
Maximum comfort and wearability, to improve subject recruitment, retention, and compliance
- Sampling frequency: 4Hz (fixed)
- Resolution: 55 fSiemens
- Range: 0 μSiemens - 80μ - 80 e:
- AC excitation, 4Hz, max.
- Electrodes (applied parts):
- Placement on either the ventral (inner) wrist or dorsal (outer) wrist.
- Sampling frequency: 1Hz
- Range: -20ºC to 70ºC
- Resolution: 0.15ºC
- Sampling frequency: 32Hz
- High sensitivity motion detection on 3 axes:
- Range ± 16g.
- Resolution: 16 bits
- Sampling frequency: 32Hz
- High sensitivity motion detection on 3 axes
- Range ± 500 degrees/sec.
- Resolution: 16 bits
Every Empatica device at a glance
Unsure which Empatica device better suits your research needs? Receive a handy comparison chart directly to your inbox, and review all sensors, specs, and digital biomarkers from our devices at any timeBy submitting your email you are consenting to receive communications about Empatica's products and services
An end to paper diaries
The Mate App keeps participants engaged while it collects, visualizes, and transmits device data to the Research Portal, where you can review it at a glance.
- Safeguard participant engagement through a simple, user-friendly app.
- Complement device data with self-reporting from participants, via daily e-diary entries, that can provide insights for understanding subjective outcomes.
- Encourages patients to stay engaged throughout your study by visualizing their sleep and activity data.
- Secure and reliable data transfer and visualization. A unique identifier also ensures that the subject’s data is partitioned correctly and stored securely.
Easily manage and access data from multiple sites and studies
The Research Portal allows research teams, CRO personnel, and study coordinators to visualize, monitor, and download data from different types of longitudinal and clinical studies on the cloud.Take a look
Maintain full control
Manage investigations, check compliance, manage multiple sites, and collect data from different types of research studies, all within one platform
Build your own team
Create a flawlessly organized hierarchy and easily delegate tasks (e.g. enrollment, data collection) with the Research Portal
Easy management of sites, studies, and teams, enabling global teamwork and easy remote subject enrollment and management
Customize the platform according to your research needs (such as type of research, type of data or events that need to be collected)
Gain full visibility raw data
Instantly access and download raw data from all devices
Potential savings per patient
Using Electronic Data Capture (EDC) can result in significant savings throughout all the phases of clinical trials. This graph illustrates an estimation of how much a pharmaceutical company can save per patient in each phase if using a solution like Empatica’s.
Total saving per patient
Total saving per patient
(Phase I and II)
Total saving per patient
(Phase I, II and III)
Support at every step of the way
The Empatica promise:
- All our clients benefit from detailed and dedicated onboarding, including an account manager and site support to walk you through every step of the process
- We handle the logistics and provide IRB materials so you can focus on your research
- Dedicated customer and technical support
- Start collecting data in less than 5 minutes with auto-generated QR codes for participant enrollment
Meeting global safety and security standards
What is your multi-site research goal?
Talk with our experts to discover how Embrace for Research can empower your investigation.Talk to our team